Skip to main content
. 2017 Jun 14;7:3504. doi: 10.1038/s41598-017-03276-w

Figure 2.

Figure 2

The stability, pharmacokinetics and biodistributions results of 99mTc-MAG3-bevacizumab. (a–b) In-vitro stability test of the probe incubated in 0.9% NaCl, PBS and serum solution at room temperature or 37 °C. c, Pharmacokinetics of 99mTc-MAG3-bevacizumab. e, Biodistribution results at 2 h, 5 h and 12 h post injection of the tracer. Abbreviation: PBS, phosphate buffered solution; %ID/g, percent injected dose per gram tissue.